
Isaac Shomer
Examiner (ID: 12146, Phone: (571)270-7671 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 1343 |
| Issued Applications | 756 |
| Pending Applications | 157 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19700114
[patent_doc_number] => 12194113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Microcapsule with a porous or hollow core and ph-sensitive shell and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/967937
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 11312
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967937
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967937 | Microcapsule with a porous or hollow core and ph-sensitive shell and use thereof | Jan 31, 2019 | Issued |
Array
(
[id] => 16459417
[patent_doc_number] => 10842744
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-11-24
[patent_title] => Performance product
[patent_app_type] => utility
[patent_app_number] => 16/261485
[patent_app_country] => US
[patent_app_date] => 2019-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1495
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16261485
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/261485 | Performance product | Jan 28, 2019 | Issued |
Array
(
[id] => 18127906
[patent_doc_number] => 11554101
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Process for encapsulating soluble biologics, therapeutics, and imaging agents
[patent_app_type] => utility
[patent_app_number] => 16/253850
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 13739
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16253850
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/253850 | Process for encapsulating soluble biologics, therapeutics, and imaging agents | Jan 21, 2019 | Issued |
Array
(
[id] => 17434701
[patent_doc_number] => 11260007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Cosmetic composition comprising particles containing high content of ceramide and method for preparing same
[patent_app_type] => utility
[patent_app_number] => 16/963038
[patent_app_country] => US
[patent_app_date] => 2019-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6052
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963038
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963038 | Cosmetic composition comprising particles containing high content of ceramide and method for preparing same | Jan 20, 2019 | Issued |
Array
(
[id] => 18460300
[patent_doc_number] => 11684577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Lipid nanoparticles
[patent_app_type] => utility
[patent_app_number] => 16/961843
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 6065
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961843
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961843 | Lipid nanoparticles | Jan 17, 2019 | Issued |
Array
(
[id] => 14578647
[patent_doc_number] => 20190216932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => CONTROLLED DRUG RELEASE LIPOSOME COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/241617
[patent_app_country] => US
[patent_app_date] => 2019-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9006
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16241617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/241617 | Controlled drug release liposome compositions and methods thereof | Jan 6, 2019 | Issued |
Array
(
[id] => 18762947
[patent_doc_number] => 11813326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => Cell-associating immunologic adjuvants for treatment enhancement
[patent_app_type] => utility
[patent_app_number] => 16/959758
[patent_app_country] => US
[patent_app_date] => 2019-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 10049
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959758
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959758 | Cell-associating immunologic adjuvants for treatment enhancement | Jan 2, 2019 | Issued |
Array
(
[id] => 16468496
[patent_doc_number] => 20200370033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => BIOLOGICAL ASSEMBLY INCLUDING BIOLOGICAL COMPONENT AND SHIELD
[patent_app_type] => utility
[patent_app_number] => 16/959812
[patent_app_country] => US
[patent_app_date] => 2018-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959812
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959812 | BIOLOGICAL ASSEMBLY INCLUDING BIOLOGICAL COMPONENT AND SHIELD | Dec 30, 2018 | Abandoned |
Array
(
[id] => 14497563
[patent_doc_number] => 20190192436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => PRODRUG COMPOSITIONS, PRODRUG NANOPARTICLES, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/234044
[patent_app_country] => US
[patent_app_date] => 2018-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16234044
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/234044 | Prodrug compositions, prodrug nanoparticles, and methods of use thereof | Dec 26, 2018 | Issued |
Array
(
[id] => 17421142
[patent_doc_number] => 11254583
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Titanium oxide powder, and dispersion and cosmetic using said powder
[patent_app_type] => utility
[patent_app_number] => 16/957376
[patent_app_country] => US
[patent_app_date] => 2018-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 15137
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16957376
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/957376 | Titanium oxide powder, and dispersion and cosmetic using said powder | Dec 26, 2018 | Issued |
Array
(
[id] => 16420627
[patent_doc_number] => 20200345825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => FORMULATION OF FISH VACCINE BASED ON LIPIDIC NANOVESICLES, IN PARTICULAR, A PROTEOLIPOSOME OR COCHLEATE, WITH ACTIVITY AGAINST THE SALMONID RICKETTSIAL SYNDROME (SRS)
[patent_app_type] => utility
[patent_app_number] => 16/957859
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16957859
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/957859 | FORMULATION OF FISH VACCINE BASED ON LIPIDIC NANOVESICLES, IN PARTICULAR, A PROTEOLIPOSOME OR COCHLEATE, WITH ACTIVITY AGAINST THE SALMONID RICKETTSIAL SYNDROME (SRS) | Dec 19, 2018 | Abandoned |
Array
(
[id] => 16710251
[patent_doc_number] => 20210077398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => LIPOSOMES COMPRISING SPHINGOMYELIN
[patent_app_type] => utility
[patent_app_number] => 16/956239
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956239
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956239 | Liposomes comprising sphingomyelin | Dec 19, 2018 | Issued |
Array
(
[id] => 14470989
[patent_doc_number] => 20190187137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => AU MULTICOMPONENT NANOMATERIALS AND SYNTHESIS METHODS
[patent_app_type] => utility
[patent_app_number] => 16/228178
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228178
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/228178 | AU multicomponent nanomaterials and synthesis methods | Dec 19, 2018 | Issued |
Array
(
[id] => 18027732
[patent_doc_number] => 11510891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Cape-loaded targeted micro vesicular cancer drug and method for developing the same
[patent_app_type] => utility
[patent_app_number] => 16/955087
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3353
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955087
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955087 | Cape-loaded targeted micro vesicular cancer drug and method for developing the same | Dec 16, 2018 | Issued |
Array
(
[id] => 16504848
[patent_doc_number] => 20200384104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => Structure-Function Relationships in the Development of Immunotherapeutic Agents
[patent_app_type] => utility
[patent_app_number] => 16/772551
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16772551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/772551 | Structure-Function Relationships in the Development of Immunotherapeutic Agents | Dec 13, 2018 | Abandoned |
Array
(
[id] => 16837734
[patent_doc_number] => 20210145746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => METHODS FOR MAKING GIANT VESICLES AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/772518
[patent_app_country] => US
[patent_app_date] => 2018-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16772518
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/772518 | Methods for making giant vesicles and their use | Dec 11, 2018 | Issued |
Array
(
[id] => 14156329
[patent_doc_number] => 20190105267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => DRY POWDER FORMULATIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/216924
[patent_app_country] => US
[patent_app_date] => 2018-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16216924
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/216924 | Dry powder formulations and methods of use | Dec 10, 2018 | Issued |
Array
(
[id] => 16913926
[patent_doc_number] => 20210187018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => CYTOBIOLOGICS AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/769930
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769930
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/769930 | CYTOBIOLOGICS AND THERAPEUTIC USES THEREOF | Dec 6, 2018 | Abandoned |
Array
(
[id] => 16726371
[patent_doc_number] => 20210093518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => PREPARATION OF SILICA-COATED CALCIUM CARBONATES WITH INCREASED SURFACE AREA AND MESOPOROSITY
[patent_app_type] => utility
[patent_app_number] => 15/733214
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733214
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733214 | Preparation of silica-coated calcium carbonates with increased surface area and mesoporosity | Dec 6, 2018 | Issued |
Array
(
[id] => 19310488
[patent_doc_number] => 12036282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Liposomal system for drug delivery
[patent_app_type] => utility
[patent_app_number] => 16/770930
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 11958
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770930
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770930 | Liposomal system for drug delivery | Dec 5, 2018 | Issued |